GUARDANT HEALTH, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- GUARDANT HEALTH, INC. payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00.
- GUARDANT HEALTH, INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- GUARDANT HEALTH, INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00.
- GUARDANT HEALTH, INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- GUARDANT HEALTH, INC. payments for repurchase of common stock for fiscal 2025 was $45.01M.
- GUARDANT HEALTH, INC. payments for repurchase of common stock for fiscal 2024 was $0.00.
- GUARDANT HEALTH, INC. payments for repurchase of common stock for fiscal 2023 was $0.00.
- GUARDANT HEALTH, INC. payments for repurchase of common stock for fiscal 2020 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $0.00 derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $45.01M 10-K · filed 2026-02-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $45.01M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $45.01M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $45.01M 10-Q · filed 2026-05-07 | $45.01M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-04-30 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-19 | |
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $172.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $7.22M 10-K · filed 2020-03-02 |
| 2016-12-31 | $100.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |